Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

838
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
838
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

986
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
986
Post-traumatic Stress Disorder01:27

Post-traumatic Stress Disorder

645
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
645
Drug Therapy01:28

Drug Therapy

320
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
320
Analgesia and Pain Management01:25

Analgesia and Pain Management

2.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.3K
Interpersonal Psychotherapy01:25

Interpersonal Psychotherapy

462
Interpersonal psychotherapy (IPT) is a structured, time-limited therapeutic approach initially developed to treat depression. It integrates key concepts from psychodynamic, humanistic, and cognitive-behavioral therapies, making it a uniquely eclectic framework. The therapy is rooted in the interpersonal theories of Adolph Meyer and Harry Stack Sullivan, as well as John Bowlby's attachment theory, and focuses on the interplay between interpersonal relationships and emotional well-being.
462

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety of Co-Administered Cannabidiol (CBD) and alcohol: a Phase I study.

Journal of cannabis research·2026
Same author

Effect of caffeine and cannabidiol (CBD) co-administration on Δ9-tetrahydrocannabinol (Δ9-THC) subjective effects, performance impairment, and pharmacokinetics.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2025
Same author

An Unexpected Activity of a Minor Cannabinoid: Cannabicyclol (CBL) Is a Potent Positive Allosteric Modulator of Serotonin 5-HT<sub>1A</sub> Receptor.

Journal of natural products·2025
Same author

Pharmacokinetics of Oral Cannabinoid Δ8-Tetrahydrocannabivarin and Its Main Metabolites in Healthy Participants.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Urinalysis and perceived effects following 2-week use of a commercial broad-spectrum cannabidiol product.

Experimental and clinical psychopharmacology·2024
Same author

Cannabielsoin (CBE), a CBD Oxidation Product, Is a Biased CB<sub>1</sub> Agonist.

Biomedicines·2024

Related Experiment Video

Updated: Feb 24, 2026

Administration of &#916;9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.1K

Cannabinoids as therapeutic for PTSD.

Mallory Je Loflin1, Kimberly A Babson1, Marcel O Bonn-Miller2

  • 1National Center for PTSD, VA Palo Alto Health Care System, USA.

Current Opinion in Psychology
|August 17, 2017
PubMed
Summary

Current treatments for post-traumatic stress disorder (PTSD) are limited. This review explores research on cannabinoids as a potential new therapy for PTSD symptoms, examining experimental, preclinical, and clinical findings.

More Related Videos

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

585
Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

4.6K

Related Experiment Videos

Last Updated: Feb 24, 2026

Administration of &#916;9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.1K
Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

585
Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

4.6K

Area of Science:

  • Neurobiology
  • Pharmacology
  • Psychiatry

Background:

  • Current pharmacotherapies for post-traumatic stress disorder (PTSD) demonstrate limited efficacy.
  • Neurobiological research suggests cannabinoids may hold therapeutic potential for PTSD.
  • There is increasing public interest in using cannabinoids for trauma symptom relief.

Purpose of the Study:

  • To provide an updated review of current research on the therapeutic value of cannabinoids for PTSD.
  • To synthesize findings from experimental, preclinical, and clinical studies.

Main Methods:

  • Literature review of experimental, preclinical, and clinical studies.
  • Analysis of neurobiological evidence.
  • Examination of observational reports on cannabinoid use for trauma.

Main Results:

  • The review synthesizes current research findings on cannabinoids and PTSD.
  • Evidence from various study types is discussed to evaluate therapeutic potential.

Conclusions:

  • Cannabinoids represent a promising area for future pharmacological treatments for PTSD.
  • Further research is warranted to fully understand the therapeutic efficacy and safety of cannabinoids for PTSD.